Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Diagnostic Laboratory, |
RCV000258079 | SCV000328312 | uncertain significance | CHARGE syndrome | 2016-09-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000258079 | SCV001377634 | benign | CHARGE syndrome | 2023-07-03 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002500964 | SCV002779649 | uncertain significance | CHARGE syndrome; Hypogonadotropic hypogonadism 5 with or without anosmia | 2022-05-18 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003144185 | SCV003831966 | uncertain significance | not provided | 2019-10-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004609338 | SCV005106931 | likely benign | Inborn genetic diseases | 2024-05-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |